litlecorn , Thailand trials , last hep c trial only one exited and was for completely personal reasons not the drug , we had 85 % success rate , had this one woman not leave we could have said the CURE word again .
- Forums
- ASX - By Stock
- BIT
- Ann: Significant Immunological Outcomes in BIT225 HIV-1 Trial
Ann: Significant Immunological Outcomes in BIT225 HIV-1 Trial, page-77
-
-
- There are more pages in this discussion • 112 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIT (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.4¢ |
Change
0.002(6.82%) |
Mkt cap ! $20.75M |
Open | High | Low | Value | Volume |
2.3¢ | 2.4¢ | 2.3¢ | $35.43K | 1.537M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 397454 | 2.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.4¢ | 112849 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 528454 | 0.022 |
2 | 260000 | 0.021 |
10 | 708273 | 0.020 |
12 | 2346701 | 0.019 |
11 | 1759636 | 0.018 |
Price($) | Vol. | No. |
---|---|---|
0.024 | 112849 | 1 |
0.025 | 220000 | 2 |
0.026 | 53847 | 1 |
0.027 | 169508 | 3 |
0.029 | 316026 | 1 |
Last trade - 12.10pm 17/10/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |
The Watchlist
JBY
JAMES BAY MINERALS LIMITED
Andrew Dornan, Executive Director
Andrew Dornan
Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online